• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Global Atlantic (Fin) Company Announces Any And All Cash Tender Offer For Subordinated Debentures Due 2051

    11/17/25 9:11:00 AM ET
    $KKR
    Investment Managers
    Finance
    Get the next $KKR alert in real time by email

    Global Atlantic (Fin) Company ("Global Atlantic") today announced that it has commenced a cash tender offer (the "Tender Offer") for any and all of the outstanding 4.70% Fixed-to-Fixed Rate Subordinated Debentures due 2051 (the "Debentures"). Global Atlantic is a wholly owned subsidiary of Global Atlantic Limited (Delaware), which has fully and unconditionally guaranteed the Debentures on a subordinated, unsecured basis. The table below sets forth additional information with respect to the Debentures and the Tender Offer.

    Title of Debentures

     

    CUSIP Number/ISIN

     

    Principal

    Amount

    Outstanding

     

    Tender

    Consideration(1)

    4.70% Fixed-to-Fixed Rate Subordinated Debentures due 2051

     

    144A: 37959GAC1 / US37959GAC15

    Reg S: U3618TAC5 / USU3618TAC54

     

    $750,000,000

     

    $1,000

    (1) Price per $1,000 principal amount of Debentures validly tendered and accepted. Holders whose Debentures are purchased pursuant to the Tender Offer will also receive accrued and unpaid interest thereon from the last interest payment date to, but not including, the Settlement Date (as defined herein).

    Timetable for the Tender Offer

    Launch Date

     

    November 17, 2025.

     

    Expiration Time

     

    5:00 p.m., New York City time, on November 21, 2025, unless the Tender Offer is extended or earlier terminated.

     

    Guaranteed Delivery Time

     

    5:00 p.m., New York City time, on the second business day after the Expiration Time (as defined below) (such day, the "Guaranteed Delivery Date"), expected to be November 25, 2025, assuming that the Tender Offer is not extended or earlier terminated.

     

    Settlement Date

     

    Assuming the Tender Offer is not extended, Global Atlantic expects the Settlement Date to be the third business day after the Expiration Time, which is expected to be November 26, 2025, for all Debentures validly tendered and accepted in the Tender Offer, including accepted Debentures that are delivered pursuant to the guaranteed delivery procedures.

    The Tender Offer is being made upon, and is subject to, the terms and conditions set forth in the Offer to Purchase dated November 17, 2025 (the "Offer to Purchase"), and the related Notice of Guaranteed Delivery (the Notice of Guaranteed Delivery, together with the Offer to Purchase, the "Offer Documents"). The Tender Offer is scheduled to expire at 5:00 p.m., New York City time, on November 21, 2025, unless extended or earlier terminated (such date and time, as the same may be extended, the "Expiration Time"). Holders must validly tender and not validly withdraw their Debentures at or prior to the Expiration Time, or deliver a properly completed and duly executed Notice of Guaranteed Delivery for their Debentures at or prior to the Expiration Time and deliver their Debentures at or prior to the Guaranteed Delivery Time, in accordance with the instructions set forth in the Offer to Purchase, to be eligible to receive the tender consideration. Holders who validly tender their Debentures may validly withdraw their tendered Debentures when and in the manner described in the Offer to Purchase.

    The consideration paid in the Tender Offer for Debentures that are validly tendered and accepted for purchase will be $1,000 per $1,000 principal amount of Debentures. Payments for Debentures purchased in the Tender Offer will include accrued and unpaid interest thereon from the last interest payment date to, but not including, the Settlement Date, which is expected to be November 26, 2025. For the avoidance of doubt, accrued interest will cease to accrue on the Settlement Date for all Debentures accepted in the Tender Offer, including accepted Debentures that are delivered pursuant to the guaranteed delivery procedures.

    Concurrently with the commencement of the Tender Offer, Global Atlantic commenced marketing a proposed new issuance of subordinated debentures (the "Proposed Debt Financing"). The Tender Offer is conditioned upon the satisfaction or waiver of certain conditions, including, among other things, the consummation of the Proposed Debt Financing on terms and conditions satisfactory to the Offeror, in its sole discretion, on or prior to the Settlement Date (the "Financing Condition"). The Tender Offer is not conditioned upon any minimum amount of Debentures being tendered. The Tender Offer may be extended, amended, terminated, or withdrawn.

    Global Atlantic has retained Wells Fargo Securities, LLC ("Wells Fargo Securities"), BNP Paribas Securities Corp. ("BNP PARIBAS"), BofA Securities, Inc. ("BofA Securities"), Morgan Stanley & Co. LLC ("Morgan Stanley"), and SMBC Nikko Securities America, Inc. ("SMBC Nikko") (collectively, the "Dealer Managers") as dealer managers for the Tender Offer. Global Bondholder Services Corporation ("GBSC") is the Information and Tender Agent.

    For additional information regarding the terms of the Tender Offer, please contact: Wells Fargo Securities at (704) 410-4820 (collect) or (866) 309-6316 (toll-free), BNP PARIBAS at (888) 210-4358 (toll-free) or (212) 841-3059, BofA Securities (980) 387-3907 (collect) or (888) 292-0070 (toll-free), Morgan Stanley at (800) 624-1808 (toll-free) or (212) 761-1057 (collect) and SMBC Nikko at (888) 284-9760. Requests for documents and questions regarding the tendering of securities may be directed to GBSC by telephone at (212) 430-3774 (for banks and brokers only), (855) 654-2015 (for all others toll-free), by email at [email protected] or to the Dealer Managers at their respective telephone numbers (toll-free or collect). Copies of the Offer to Purchase and Notice of Guaranteed Delivery are available at https://www.gbsc-usa.com/globalatlantic/.

    If you do not tender your Debentures or if you tender Debentures that are not accepted for purchase, they will remain outstanding. If Global Atlantic consummates the Tender Offer, the trading market for your outstanding Debentures may be significantly more limited. For a discussion of this and other risks, see "Certain Considerations" in the Offer to Purchase.

    THIS PRESS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT AN OFFER OR SOLICITATION TO PURCHASE DEBENTURES. THE TENDER OFFER IS BEING MADE SOLELY PURSUANT TO THE OFFER DOCUMENTS, WHICH SET FORTH THE COMPLETE TERMS OF THE TENDER OFFER THAT HOLDERS OF THE DEBENTURES SHOULD CAREFULLY READ PRIOR TO MAKING ANY DECISION.

    GLOBAL ATLANTIC RESERVES THE RIGHT, SUBJECT TO APPLICABLE LAW, IN ITS SOLE DISCRETION, TO: (I) WAIVE ANY AND ALL CONDITIONS TO THE TENDER OFFER, INCLUDING THE FINANCING CONDITION, AT ANY TIME AND FROM TIME TO TIME AT OR PRIOR TO THE EXPIRATION TIME; (II) EXTEND OR TERMINATE THE TENDER OFFER; OR (III) OTHERWISE AMEND THE TENDER OFFER IN ANY RESPECT.

    THE OFFER DOCUMENTS AND THIS PRESS RELEASE DO NOT CONSTITUTE AN OFFER TO PURCHASE, OR THE SOLICITATION OF AN OFFER TO SELL, DEBENTURES IN ANY JURISDICTION IN WHICH, OR TO OR FROM ANY PERSON TO OR FROM WHOM, IT IS UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION UNDER APPLICABLE SECURITIES OR BLUE SKY LAWS. IN ANY JURISDICTION IN WHICH THE SECURITIES, BLUE SKY OR OTHER LAWS REQUIRE THE TENDER OFFER TO BE MADE BY A LICENSED BROKER OR DEALER, THE TENDER OFFER WILL BE DEEMED TO BE MADE ON BEHALF OF GLOBAL ATLANTIC BY THE DEALER MANAGERS, IF ANY DEALER MANAGER IS A LICENSED BROKER OR DEALER UNDER THE LAWS OF SUCH JURISDICTION, OR BY ONE OR MORE REGISTERED BROKERS OR DEALERS THAT ARE LICENSED UNDER THE LAWS OF SUCH JURISDICTION.

    NO ACTION HAS BEEN OR WILL BE TAKEN IN ANY JURISDICTION THAT WOULD PERMIT THE POSSESSION, CIRCULATION OR DISTRIBUTION OF EITHER THIS PRESS RELEASE, THE OFFER TO PURCHASE OR ANY MATERIAL RELATING TO GLOBAL ATLANTIC OR THE DEBENTURES UNLESS SPECIFIED ACTION FOR THAT PURPOSE IS UNDERTAKEN. ACCORDINGLY, NEITHER THIS PRESS RELEASE, THE OFFER TO PURCHASE NOR ANY OTHER OFFERING MATERIAL OR ADVERTISEMENTS IN CONNECTION WITH THE TENDER OFFER MAY BE DISTRIBUTED OR PUBLISHED, IN OR FROM ANY SUCH COUNTRY OR JURISDICTION, EXCEPT IN COMPLIANCE WITH ANY APPLICABLE RULES OR REGULATIONS OF ANY SUCH COUNTRY OR JURISDICTION. PERSONS INTO WHOSE POSSESSION THIS PRESS RELEASE OR THE OFFER TO PURCHASE COME ARE REQUIRED BY GLOBAL ATLANTIC, THE DEALER MANAGERS AND THE INFORMATION AGENT AND TENDER AGENT TO INFORM THEMSELVES ABOUT, AND TO OBSERVE, ANY SUCH RESTRICTIONS.

    WHILE GLOBAL ATLANTIC IS NOT AWARE OF ANY JURISDICTION WHERE THE MAKING OF THE TENDER OFFER IS NOT IN COMPLIANCE WITH APPLICABLE LAW, IF GLOBAL ATLANTIC BECOMES AWARE OF ANY SUCH JURISDICTION, GLOBAL ATLANTIC WILL MAKE A GOOD FAITH EFFORT TO COMPLY WITH APPLICABLE LAW OR SEEK TO HAVE SUCH LAW DECLARED INAPPLICABLE TO THE TENDER OFFER. IF, AFTER SUCH GOOD FAITH EFFORT, GLOBAL ATLANTIC CANNOT COMPLY WITH ANY SUCH LAW, THE TENDER OFFER WILL NOT BE MADE TO (NOR WILL TENDERS BE ACCEPTED FROM OR ON BEHALF OF) HOLDERS RESIDING IN SUCH JURISDICTION.

    NONE OF GLOBAL ATLANTIC, ITS BOARD OF DIRECTORS, THE DEALER MANAGERS, THE INFORMATION AND TENDER AGENT OR THE TRUSTEE FOR THE DEBENTURES IS MAKING ANY RECOMMENDATION AS TO WHETHER HOLDERS SHOULD TENDER DEBENTURES IN THE TENDER OFFER. EACH HOLDER MUST MAKE HIS, HER OR ITS OWN DECISION AS TO WHETHER TO TENDER DEBENTURES AND, IF SO, AS TO THE PRINCIPAL AMOUNT OF DEBENTURES TO TENDER.

    About Global Atlantic

    Global Atlantic is a leading provider of retirement security and investment solutions with operations in the U.S. and Bermuda. As a wholly owned subsidiary of KKR (NYSE:KKR), a leading global investment firm, Global Atlantic combines deep insurance expertise with KKR's powerful investment capabilities. Together, they deliver long-term financial security for millions of individuals and risk-focused, client-driven solutions for institutions. With a broad suite of annuity, preneed life insurance, reinsurance, and investment solutions, Global Atlantic, through its issuing companies, helps people achieve their financial goals with confidence. For more information, please visit www.globalatlantic.com.

    Global Atlantic is the marketing name for The Global Atlantic Financial Group LLC and its subsidiaries, including Accordia Life and Annuity Company, Commonwealth Annuity and Life Insurance Company, Forethought Life Insurance Company and Global Atlantic Re Limited. Each subsidiary is responsible for its own financial and contractual obligations. These subsidiaries are not authorized to do business in New York.

    Cautionary Statement

    This press release contains forward-looking statements and cautionary statements. Some of the forward-looking statements can be identified by the use of forward-looking terms such as "believes," "expects," "may," "will," "should" or other comparable words or other statements that do not relate strictly to historical or factual matters. Forward-looking statements include, without limitation, all matters that are not historical facts. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond our control. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in this press release. Important risk factors regarding Global Atlantic can be found in the Offer to Purchase and are incorporated herein by reference. Furthermore, all forward-looking statements made in this press release are qualified by these cautionary statements. These forward-looking statements are made only as of the date of this press release, and we do not undertake any obligation, other than as may be required by law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, and changes in future operating results over time or otherwise.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251114500890/en/

    Global Atlantic (Fin) Company

    Email: [email protected]

    Get the next $KKR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $KKR

    DatePrice TargetRatingAnalyst
    2/24/2026$137.00Outperform
    RBC Capital Mkts
    1/28/2026$144.00Hold → Buy
    HSBC Securities
    1/14/2026$131.00Buy → Hold
    TD Cowen
    12/11/2025$176.00Buy
    UBS
    7/14/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    7/9/2025$142.00Buy → Hold
    HSBC Securities
    6/30/2025$150.00Overweight
    Piper Sandler
    5/14/2025$150.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $KKR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Barakett Timothy R bought $4,723,500 worth of shares (50,000 units at $94.47) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    3/5/26 7:30:13 PM ET
    $KKR
    Investment Managers
    Finance

    Large owner Kkr Group Partnership L.P. sold $807,546,115 worth of shares (19,715,000 units at $40.96), disposed of 402,773 shares and gifted 81,213 shares (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Reporting)

    3/4/26 7:46:52 PM ET
    $KKR
    Investment Managers
    Finance

    Co-Chief Executive Officer Bae Joseph Y bought $4,428,000 worth of shares (50,000 units at $88.56) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    3/3/26 4:34:04 PM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Esperion Therapeutics and Corstasis Therapeutics Announce Esperion's Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

    – Enbumyst™ Is the First and Only FDA-Approved Nasal Spray Loop Diuretic for Edema Associated with Congestive Heart Failure, Expected to Leverage Esperion's Established Cardiovascular Commercial Infrastructure, Synergistically Expand Product Portfolio and Accelerate Double-Digit Revenue Growth – – Upfront Cash Payment of $75 Million, Royalties on Worldwide Enbumyst Sales and Up to $180 Million in Potential Milestone Payments Tied to Certain Commercial and Regulatory Achievements – – Esperion to Host Conference Call on Tuesday, March 3, 2026 at 8:00 am ET – ANN ARBOR, Mich. and HENDERSON, Nev., March 03, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) and Corstasis Therapeutics Inc., a p

    3/3/26 6:00:00 AM ET
    $ESPR
    $KKR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Managers
    Finance

    KKR to Present at the 2026 RBC Capital Markets Financial Institutions Conference

    KKR & Co. Inc. (NYSE:KKR) announced today that Robert H. Lewin, Chief Financial Officer, will present at the 2026 RBC Capital Markets Financial Institutions Conference on Wednesday, March 11, 2026 at 9:20AM ET. A live webcast of the presentation will be available on the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. For those unable to listen to the live webcast, a replay will be available on the website shortly after the event. Any questions regarding the webcast may be addressed to KKR's Investor Relations team at [email protected]. ABOUT KKR KKR is a leading global investment firm that offers alternative asset management as well as

    2/26/26 4:15:00 PM ET
    $KKR
    Investment Managers
    Finance

    FS KKR Capital Corp. Announces Fourth Quarter and Full Year 2025 Results; Declares First Quarter 2026 Distribution of $0.48 per Share

    PHILADELPHIA and NEW YORK, Feb. 25, 2026 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter and year ended December 31, 2025, and that its board of directors has declared a first quarter 2026 distribution of $0.48 per share. Financial and Operating Highlights for the Quarter Ended December 31, 2025(1)Net investment income of $0.48 per share, compared to $0.57 per share for the quarter ended September 30, 2025Adjusted net investment income(2) of $0.52 per share, compared to $0.57 per share for the q

    2/25/26 4:15:00 PM ET
    $FSK
    $KKR
    Investment Managers
    Finance

    $KKR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Barakett Timothy R bought $4,723,500 worth of shares (50,000 units at $94.47) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    3/5/26 7:30:13 PM ET
    $KKR
    Investment Managers
    Finance

    Director Dillon Mary N bought $2,021,586 worth of shares (22,225 units at $90.96) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    3/3/26 4:34:01 PM ET
    $KKR
    Investment Managers
    Finance

    Co-Chief Executive Officer Bae Joseph Y bought $4,428,000 worth of shares (50,000 units at $88.56) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    3/3/26 4:34:04 PM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    SEC Filings

    View All

    SEC Form DEFA14A filed by KKR & Co. Inc.

    DEFA14A - KKR & Co. Inc. (0001404912) (Filer)

    3/2/26 8:32:24 AM ET
    $KKR
    Investment Managers
    Finance

    SEC Form DEFA14A filed by KKR & Co. Inc.

    DEFA14A - KKR & Co. Inc. (0001404912) (Filer)

    2/27/26 5:01:59 PM ET
    $KKR
    Investment Managers
    Finance

    SEC Form DEFA14A filed by KKR & Co. Inc.

    DEFA14A - KKR & Co. Inc. (0001404912) (Filer)

    2/27/26 5:00:39 PM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on KKR with a new price target

    RBC Capital Mkts initiated coverage of KKR with a rating of Outperform and set a new price target of $137.00

    2/24/26 7:55:00 AM ET
    $KKR
    Investment Managers
    Finance

    KKR upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded KKR from Hold to Buy and set a new price target of $144.00

    1/28/26 7:11:28 AM ET
    $KKR
    Investment Managers
    Finance

    KKR downgraded by TD Cowen with a new price target

    TD Cowen downgraded KKR from Buy to Hold and set a new price target of $131.00

    1/14/26 8:26:34 AM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    Leadership Updates

    Live Leadership Updates

    View All

    KKR-led Consortium Drives Further Investment in Sylvan

    Global investment firm KKR today announced the completion of an additional investment in Sylvan, a world-leading fungal biotechnology company (the "Company"), through funds managed by KKR with participation from new investors and a follow-on investment from existing investor, Novo Holdings, which increased its ownership stake in the Company as part of this round. Following the investment, KKR remains the majority investor in Sylvan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120305013/en/ Founded in 1932, Sylvan is a world-leading mushroom spawn and fungal biotechnology company. The company seeks to harness the potential

    1/20/26 8:02:00 PM ET
    $KKR
    Investment Managers
    Finance

    Peak Re Welcomes KKR and Quadrantis Capital as Minority Investors

    Peak Reinsurance Company Limited ("Peak Re" or the "Company") and KKR, a leading global investment firm, today announced that funds managed by KKR and Quadrantis Capital have entered into definitive agreements to acquire minority stakes in Peak Re via Peak Reinsurance Holdings Limited. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251020924186/en/ Upon completion, KKR and Quadrantis Capital are expected to hold approximately 11.27% and approximately 1.80% of Peak Re's issued share capital, respectively, with the remaining approximately 86.71% continuing to be held by the majority shareholder, Fosun International Limited. Pruden

    10/20/25 9:05:00 PM ET
    $KKR
    Investment Managers
    Finance

    KKR Appoints Craig Arnold to Board

    KKR & Co. Inc. (NYSE:KKR) today announced that Craig Arnold has been appointed to the Board of Directors effective September 23, 2025. His appointment will bring the number of independent directors to eleven out of a total of fifteen Board seats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250924641078/en/Craig Arnold Mr. Arnold is the former Chairman and Chief Executive Officer of Eaton Corporation, a global intelligent power management company. KKR's other Board members are: Henry Kravis (Co-Founder and Co-Executive Chairman of KKR), George Roberts (Co-Founder and Co-Executive Chairman of KKR), Joseph Bae (Co-Executive Of

    9/24/25 4:30:00 PM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    Financials

    Live finance-specific insights

    View All

    Esperion Therapeutics and Corstasis Therapeutics Announce Esperion's Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

    – Enbumyst™ Is the First and Only FDA-Approved Nasal Spray Loop Diuretic for Edema Associated with Congestive Heart Failure, Expected to Leverage Esperion's Established Cardiovascular Commercial Infrastructure, Synergistically Expand Product Portfolio and Accelerate Double-Digit Revenue Growth – – Upfront Cash Payment of $75 Million, Royalties on Worldwide Enbumyst Sales and Up to $180 Million in Potential Milestone Payments Tied to Certain Commercial and Regulatory Achievements – – Esperion to Host Conference Call on Tuesday, March 3, 2026 at 8:00 am ET – ANN ARBOR, Mich. and HENDERSON, Nev., March 03, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) and Corstasis Therapeutics Inc., a p

    3/3/26 6:00:00 AM ET
    $ESPR
    $KKR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Managers
    Finance

    FS KKR Capital Corp. Announces Fourth Quarter and Full Year 2025 Results; Declares First Quarter 2026 Distribution of $0.48 per Share

    PHILADELPHIA and NEW YORK, Feb. 25, 2026 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter and year ended December 31, 2025, and that its board of directors has declared a first quarter 2026 distribution of $0.48 per share. Financial and Operating Highlights for the Quarter Ended December 31, 2025(1)Net investment income of $0.48 per share, compared to $0.57 per share for the quarter ended September 30, 2025Adjusted net investment income(2) of $0.52 per share, compared to $0.57 per share for the q

    2/25/26 4:15:00 PM ET
    $FSK
    $KKR
    Investment Managers
    Finance

    Keurig Dr Pepper Announces Updated Financing Plan for JDE Peet's Acquisition

    Company strengthens balance sheet by further reducing projected leverage and attracts additional high-quality investorsBURLINGTON, Mass. and FRISCO, Texas, Feb. 23, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ:KDP, ", the Company", )) today announced updated financing plans and transaction timelines for the acquisition of JDE Peet's and subsequent planned separation into two independent companies ("Beverage Co." and "Global Coffee Co." pending the announcement of official corporate names).Key developments include:A targeted close of the JDE Peet's acquisition in early April 2026, with expected combined net leverage of approximately 4.5x1An agreement to upsize the previously announced B

    2/23/26 4:30:00 PM ET
    $APO
    $KDP
    $KKR
    Investment Managers
    Finance
    Beverages (Production/Distribution)
    Consumer Staples

    $KKR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by KKR & Co. Inc.

    SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)

    11/12/24 3:50:17 PM ET
    $KKR
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by KKR & Co. Inc.

    SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)

    11/4/24 11:48:27 AM ET
    $KKR
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by KKR & Co. Inc. (Amendment)

    SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)

    2/13/24 6:32:37 PM ET
    $KKR
    Investment Managers
    Finance